As a follow up to the refusal of the Indian government regarding relaxing India’s ban on hydroxychloroquine tablets so that the drug could be used to treat COVID-19 patients in the US, president Donald Trump made a what can be easily considered aggressive and a warning statement in a recent press conference.
The President explicitly warned India of possible retaliation if it doesn’t allow the export of Hydroxychloroquine tablets to the United States (US).
“So, I would be surprised if that were his decision. He’d have to tell me that. I spoke to him Sunday morning, called him, and I said we’d appreciate your allowing our supply to come out. If he doesn’t allow it to come out, that would be okay, but of course there may be retaliation. Why wouldn’t there be?” Trump said during a press briefing at the White House on Monday.
The whole issue started when Trump requested for India’s assistance in fighting coronavirus by anti-malarial drugs, hours after India banned the export of the anti-malarial drug. While similar requests have also been made by India’s other neighbors such as Sri Lanka and Nepal, a response by the indian government states that India has been a significant partner of the US in the pharmaceutical sector and it expects similar cooperation to continue between the economies.